Subtype-selective antagonism of NMDA receptors by nylidrin

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 197-208

  Whittemore, E R ^a   Ilyin, V I ^a   Konkoy, C S ^a   Woodward, R M ^a  

^a Department of Pharmacokinetics and Drug Metabolism   (United States)

Author keywords

Allosteric antagonism; CP 101,606; Glutamate receptor; Haloperidol; Ifenprodil; Ro 25 6981; Xenopus oocyte

Indexed keywords

BUPHENINE; ELIPRODIL; GLUTAMATE RECEPTOR; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PIPERIDINE DERIVATIVE; TRAXOPRODIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; XENOPUS;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DRUG SYNERGISM; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; NEURONS; NYLIDRIN; OOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; XENOPUS;

EID: 0030662439     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01292-2     Document Type: Article

References (50)

1. Arellano R.O., Woodward R.M., Miledi R. A monovalent cationic conductance that is blocked by extracellular divalent cations in Xenopus oocytes. J. Physiol. 484:1995;593-604.
2. Ariëns E.J., Waelen M.J.G.A., Sonneville P.F., Simmons A.M. The pharmacology of catecholamines and their derivatives. Arzneim.-Forsch. Drug Res. 13:1962;541-546.
3. 2+ channels and in gerbil global cerebral ischaemia. Eur. J. Pharmacol. 299:1996;103-112.
4. 125I ]Ifenprodil: A convenient radioligand for binding and autoradiographic studies of the polyamine-sensitive site of the NMDA receptor Neurosci. Lett. 124:1991;187-189.
5. Beart P.M., Ryan M.C., Mercer L.D., Jarrott B., Wong M.C. Heterocyclic amino alcohols related to ifenprodil as σ receptor ligands: Binding and conformational analyses. Eur. J. Pharmacol. 269:1994;193-200.
6. Ben-Ari Y., Cherubini E., Krnjevic K. Changes in voltage-dependence of NMDA currents during development. Neurosci. Lett. 94:1988;88-92.
7. Bilezikian J.P., Dornfeld A.M., Gammon D.E. Structure-binding-activity analysis of beta-adrenergic amines-I. Biochem. Pharmacol. 27:1978;1445-1454.
8. Chenard B.L., Bordner J., Butler T.W., Chambers L.K., Collins M.A., De Costa D.L., Ducat M.F., Dumont M.L., Fox C.B., Mena E.E., Meniti F.S., Nielsen J., Pagnozzi M.J., Richter K.E.G., Ronau R.T., Shalaby I.A., Stemple J.Z., White W.F. (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem. 38:1995;3138-3145.
9. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
10. Fichtl B., Felix W. Central cardiovascular effects of nylidrin (buphenine). Eur. J. Pharmacol. 65:1980;333-339.
11. Fletcher E.J., MacDonald J.F. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235:1993;291-295.
12. Gallagher M.J., Huang H., Prichett D.B., Lynch D.R. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271:1996;9603-9611.
13. 3H ]dihydroergocryptine of the α-adrenergic receptor of the hepatic plasma membrane J. Biol. Chem. 253:1978;1114-1120.
14. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth S.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflüg. Arch. 391:1981;85-100.
15. A receptor. Mol. Pharmacol. 49:1996;897-906.
16. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
17. Huettner J.E., Bean B.P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. 85:1988;1307-1311.
18. Ilyin V.I., Whittemore E.R., Guastella J., Weber E., Woodward R.M. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol. Pharmacol. 50:1996;1541-1550.
19. Ilyin V.I., Whittemore E.R., Tran M., Shen K.-Z., Cai S.-X., Kher S.M., Keana J.F.W., Weber E., Woodward R.M. Pharmacology of ACEA-1416: A potent systemically active N-methyl-D-aspartate receptor glycine site antagonist. Eur. J. Pharmacol. 310:1996;107-114.
20. Kew J.N.C., Trube G., Kemp J.A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect to ifenprodil in rat cultured cortical neurons. J. Physiol. 497:1996;761-772.
21. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimua K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanihsi T., Arakawa M., Mishina M. Molecular diversity of the NMDA receptor channel. Nature. 358:1992;36-41.
22. Legendre P., Westbrook G.L. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol. Pharmacol. 40:1991;289-298.
23. MacDonald J.W., Johnston M.V. Pharmacology of NMDA-induced brain injury in an in vivo perinatal rat model. Synapse. 6:1990;179-188.
24. 125I -Ifenprodil: Synthesis and characterization of binding to a polyamine-sensitive site in cerebral cortical membranes J. Neurochem. 61:1993;120-126.
25. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
26. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
27. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
28. Mott D.D., Zhang S., Washburn M.S., Fendley M., Dingledine R. CP-101,606 antagonizes NMDA receptors by interacting with the polyamine modulatory site. Soc. Neurosci. Abstr. 22:1996;66.
29. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
30. Pahk, A.J., Williams, K., 1997. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci. Lett., in press.
31. Priestly T., Laughton P., Myers J., Le Bourdelles B., Kirby J., Whiting P.J. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1A/NR2A and NR1A/2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol. 48:1995;841-848.
32. Scatton, B., Avenet, P., Benavides, J., Carter, C., Duverger, D., Oblin, A., Perrault, G., Sanger, D.J., Schoemaker, H., 1994. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists-ifenprodil and eliprodil. In: Palfreyman, M.G., Reynolds, I.J., Skolnick, P. (Eds.), Direct and Allosteric Control of Glutamate Receptors. CRC Press, Boca Raton, FL, pp. 139-154.
33. Schoemaker, H., Pigasse, S., Caboi, F., Oblin, A., 1994. Polyamine effects on radioligand binding to receptors and recognition sites. In: Carter, C. (Ed.), The Neuropharmacology of Polyamines. Academic Press, San Diego, CA, pp. 107-154.
34. Shalaby I.A., Chenard B.L., Prochniak M.L., Butler T.W. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture. J. Pharmacol. Exp. Ther. 260:1992;925-932.
35. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 368:1994;144-147.
36. Small D.L., Buchan A.M. NMDA antagonists: Their role in neuroprotection. Int. Rev. Neurobiol. 40:1997;137-171.
37. Sucher N.J., Awobuluyi M., Choi Y.-B., Lipton S.A. NMDA receptors: From genes to channels. Trends Pharmacol. 17:1996;348-355.
38. Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185:1992;826-832.
39. Tang C.-M., Dichter M., Morad M. Modulation of the N-methyl-D-aspartate channel by extracellular pH. Proc. Natl. Acad. Sci. 87:1990;6445-6449.
40. Trube G., Ehrhard P., Malherbe P., Huber G. The selectivity of Ro 25-6981 for NMDA receptor subtypes expressed in Xenopus oocytes. Soc. Neurosci. Abstr. 22:1996;1760.
41. Vartanian M.G., Boxer P.A. Prevention of NMDA-induced brain injury in neonatal rats by subtype-selective NMDA (NR2B) antagonists. Soc. Neurosci. Abstr. 22:1996;1279.
42. Whittemore E.R., Ilyin V.I., Woodward R.M. Subtype-selective antagonism of NMDA receptors by nylidrin. Soc. Neurosci. Abstr. 22:1996;1279.
43. Whittemore, E.R., Ilyin, V.I., Woodward, R.M., 1997. Antagonism of N-methyl-D-aspartate receptors by σ (sigma) site ligands: Potency, subtype-selectivity, and mechanisms of inhibition. J. Pharm. Exp. Ther., in press.
44. Willetts J., Balster R.L., Leander J.D. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. 11:1990;423-428.
45. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44:1993;851-859.
46. Williams K., Russell S.L., Shen Y.M., Molinoff P.B. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 10:1993;267-278.
47. Woodward R.M., Huettner J.E., Guastella J., Keana J.F.W., Weber E. In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:1995;568-581.
48. Yen T.T., Pearson D.V. Nylidrin: A potent anti-hypertensive agent in hypertensive rats. Res. Commun. Chem. Path. Pharmacol. 23:1979;11-27.
49. Zhong J., Russell S.L., Prichett D.B., Molinoff P.B., Williams K. Expression of messenger RNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45:1994;846-852.
50. Zukin R.S., Bennett M.V.L. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 8:1995;306-313.